University of Washington-Seattle Campus · Biomedical Engineering · EngineeringThe Cancer Microenvironment Lab
Albert Folch · Seattle, Washington
Research Focus
Dr. Albert Folch's lab focuses on advancing cancer treatment through innovative drug testing technologies. By integrating microfluidics with advanced biosensors, they aim to create platforms that simulate the tumor microenvironment, allowing for more accurate testing of cancer therapies. Their work strives to enhance personalized medicine and improve the success rate of drug therapies, especially immunotherapies.
microfluidicstumor microenvironmentdrug testingimmunotherapybiosensorsproteomicsmachine learningcombination therapiespatient-derived modelshigh-throughput testing
Research Aims
4AIM 01Develop a microfluidic platform for drug testing on intact tumor biopsies.
AIM 02Integrate electrochemical sensors to monitor tumor response in real-time.
AIM 03Create high-throughput testing methods for combination immunotherapy.
AIM 04Utilize patient-derived tumor models for personalized treatment assessment.
Skills the Lab Values
microfluidic device fabricationcell culture techniquesrobotic automationproteomics analysiselectrochemical sensingdata analysis with Pythonmulti-immunohistochemistrycytokine profilinghuman tumor biopsy processingmachine learning techniques
Output against the department
Publications143bottom 32% of dept.589th of 868
this lab
most publishedleast published
Citations9.2ktop 38% of dept.329th of 868
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.